Alligator Bioscience shares
Alligator Biosciences CEO about the issue
Alligator Bioscience develops tumor-targeted antibody-based treatments for cancer. At the beginning of the year, the company reported positive interim results from OPTIMIZE-1, a phase...
Intervju
Video
Alligator prepares for new milestones with mitazalimab
The objective response rate of 52 percent measured with...
BioStock Investor Pitch: Alligator Bioscience
Alligator Bioscience has had a good start to...
Intervju
Video
FDA approves Alligator's Phase II study
Alligator BioScience continues to make progress with its...
Intervju